| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 07/16/2003 | EP1326987A1 Chimeric cytoplasmic signalling molecules derived from cd137 |
| 07/16/2003 | EP1326980A2 Methods of treatment using wisp polypeptides |
| 07/16/2003 | EP1326971A2 Proteins and nucleic acids encoding same |
| 07/16/2003 | EP1326896A2 Human anti-cd40 antibodies |
| 07/16/2003 | EP1326894A2 Novel tumor-associated marker |
| 07/16/2003 | EP1326893A2 Plasma fraction containing bikunin, method for the production thereof and use of the same |
| 07/16/2003 | EP1326869A1 Pyrrole-condensed morphinoid derivatives |
| 07/16/2003 | EP1326868A1 Morphinoid derivatives as delta-opioid agonists and antagonists |
| 07/16/2003 | EP1326867A2 Bridged piperazine derivatives |
| 07/16/2003 | EP1326866A1 Substituted 3.4-dihydro-pyrido[1,2-a]pyrimidines |
| 07/16/2003 | EP1326864A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 07/16/2003 | EP1326859A1 Quinazoline derivatives with anti-tumour activity |
| 07/16/2003 | EP1326857A2 Diazacycloalkanedione derivatives which are useful as lfa-1 antagonists |
| 07/16/2003 | EP1326856A1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity |
| 07/16/2003 | EP1326853A1 New thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors |
| 07/16/2003 | EP1326848A1 Dihydropyrimidine derivatives as cysteine protease inhibitors |
| 07/16/2003 | EP1326847A1 (2s)-2-(adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use |
| 07/16/2003 | EP1326843A1 Pyrazole derivatives for the treatment of viral diseases |
| 07/16/2003 | EP1326841A1 Pyridinone derivatives for treatment of atherosclerosis |
| 07/16/2003 | EP1326828A1 Beta-amino acid derivatives as integrin receptor antagonists |
| 07/16/2003 | EP1326826A1 Use of amino acids for treating pain |
| 07/16/2003 | EP1326822A2 Ketone compounds and compositions for cholesterol management and related uses |
| 07/16/2003 | EP1326630A2 Use of glp-1 and glp-2 peptides |
| 07/16/2003 | EP1326626A2 Methods for treating rheumatoid arthritis using il-17 antagonists |
| 07/16/2003 | EP1326619A2 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 07/16/2003 | EP1326613A1 Use of substituted imidazo 1,2-a]pyridine-, imidazo 1,2-a]pyrimidine and imidazo 1,2-a]pyrazine-3-yl-amine derivatives for producing nos-inhibiting medicaments |
| 07/16/2003 | EP1326606A2 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 07/16/2003 | EP1326593A1 ESTROGEN RECEPTOR-$g(b) LIGANDS |
| 07/16/2003 | EP1326590A2 Patch comprising diclofenac |
| 07/16/2003 | EP1326589A2 Nanoparticles |
| 07/16/2003 | EP1326584A1 Delivery system and method of treating or preventing otitis media |
| 07/16/2003 | EP1326583A1 Medication delivery devices |
| 07/16/2003 | EP1246809B1 5-aryl-1h-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them |
| 07/16/2003 | EP1181284B1 Diphenyl-1,2,3-thiadiazol-3-oxides, compositions and methods of use |
| 07/16/2003 | EP1165555B1 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands |
| 07/16/2003 | EP1155000B1 2-aminopyridines containing fused ring substituents |
| 07/16/2003 | EP1109789B1 Triptolide prodrugs having high aqueous solubility |
| 07/16/2003 | EP1084104B1 Nitric oxide synthase inhibitors |
| 07/16/2003 | EP1070069B1 Bicyclic hydroxamic acid derivatives |
| 07/16/2003 | EP1028955B1 Pyrimidinone compounds and pharmaceutical compositions containing them |
| 07/16/2003 | EP1017385B1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-beta 1 |
| 07/16/2003 | EP0983059B1 Process for making flurbiprofen lozenges |
| 07/16/2003 | EP0832076B1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
| 07/16/2003 | EP0758328B1 Anti-cancer compounds containing cyclopentaquinazoline ring |
| 07/16/2003 | CN1430625A 3-nitrogen-6,7-dioxygen steroids and uses thereof |
| 07/16/2003 | CN1430620A Macrolides compound |
| 07/16/2003 | CN1430615A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/16/2003 | CN1430614A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/16/2003 | CN1430611A 1,4-diazepan-2,5-dione derivatives and their use as NK-1 receptor antagonists |
| 07/16/2003 | CN1430607A Benzophenones as inhibitors of IL-1 beta and TNF-alpha |
| 07/16/2003 | CN1430602A Ary-and heteroaryl sulfonates compounds |
| 07/16/2003 | CN1430599A Phenylglycine derivatives |
| 07/16/2003 | CN1430597A Novel MMP-2/MMP-9 inhibitors |
| 07/16/2003 | CN1430516A Crystal structures of P-selectin, P-and E-selectin complexes and use thereof |
| 07/16/2003 | CN1430505A Microspheres for active embolization |
| 07/16/2003 | CN1430474A Tryptophan source from plants and uses therefor |
| 07/16/2003 | CN1429616A New preparation of compound Chinese medicine for treating osteoarthritis and its preparation method |
| 07/16/2003 | CN1429611A Greater celandine extract and its preparation method and application |
| 07/16/2003 | CN1429608A Formula for treating neck lymphadenopathy |
| 07/16/2003 | CN1429601A Heat-Clearing away heat and toxic material and subsidence of swelling powder |
| 07/16/2003 | CN1429599A Medicine for treating damp arthralgia |
| 07/16/2003 | CN1429571A Notoginseng pain relieving plaster and its preparation method |
| 07/16/2003 | CN1429566A Dysmenorrhea pain relieving egg |
| 07/16/2003 | CN1429565A Liquid for remission and treating mastadenitis and mammary suppuration |
| 07/16/2003 | CN1429556A Muscle strong agent and anti-inflammatory agent |
| 07/16/2003 | CN1114604C Bicyclic aryl carboxamides and their therapeutic use |
| 07/16/2003 | CN1114598C Aromatic compounds and pharmaceutical compositions containing them |
| 07/16/2003 | CN1114597C Quinoline derivs |
| 07/16/2003 | CN1114423C External used liquid for treating tumour, hyperplastic surgical disease |
| 07/16/2003 | CN1114420C Medicine for treating intractable ischias and chronic lumbocrural pain and its preparing process |
| 07/16/2003 | CN1114418C Medicine for treating rheumatism and aploplexy and its preparation process |
| 07/16/2003 | CN1114403C Vitronectin receptor antagonists |
| 07/16/2003 | CN1114402C Isothiazolones compound, preparation containing them and its use |
| 07/15/2003 | US6593472 NK-1 receptor active amine oxide prodrugs |
| 07/15/2003 | US6593370 Topical capsaicin preparation |
| 07/15/2003 | US6593368 Combination with NMDA receptor antagonists, NSAIDs, and analgesics. |
| 07/15/2003 | US6593363 The present invention relates to diterpene derivatives prepared from the components which are extracted from Acanthopanax Koreanum and represented by Chemical Formula (1). |
| 07/15/2003 | US6593359 Use of a RAR-γ-specific agonist ligand for increasing the rate of apoptosis |
| 07/15/2003 | US6593357 Treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease. |
| 07/15/2003 | US6593354 Substituted benzoxazole compounds |
| 07/15/2003 | US6593353 p53 inhibitors and therapeutic use of the same |
| 07/15/2003 | US6593351 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 07/15/2003 | US6593347 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 07/15/2003 | US6593343 Antiinflammatory agents; autoimmune diseases |
| 07/15/2003 | US6593339 Use of compounds as antibacterial agents |
| 07/15/2003 | US6593333 Substituted anilino-quinazoline (or quinoline) compounds and use thereof |
| 07/15/2003 | US6593327 Compounds and compositions as protease inhibitors |
| 07/15/2003 | US6593326 Useful as anti-cancer agents; and processes for their manufacture and pharmaceutical compositions containing them are described. Apoptotic effect in a warm-blooded animal such as man. |
| 07/15/2003 | US6593292 Amidine and/or guanidine substituted peptoid and drug conjugates for drug delivery across endo/epithelial tissue |
| 07/15/2003 | US6592911 (−)-Olivil as antioxidant which is obtained from a new natural source namely Stereospermum personatum |
| 07/15/2003 | US6592907 Treating an eye infections; cleansing a contact lens in place on an eye |
| 07/15/2003 | US6592901 Highly compressible ethylcellulose for tableting |
| 07/15/2003 | US6592896 Medicinal composition and method of using it |
| 07/15/2003 | US6592894 Hydrogel-isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
| 07/15/2003 | US6592868 Produced by hybridoma having ATCC Accession Number HB 10916 |
| 07/15/2003 | US6592860 Composition and applicator for topical substance delivery |
| 07/15/2003 | CA2316731C Concentrated and stabilized antipyretic compound for veterinary use to be added to animal feed and process for adding the said compound to animal drinking water |
| 07/15/2003 | CA2238465C Triaromatic compounds, compositions containing them and uses |
| 07/15/2003 | CA2180843C Pyridine modulators of acetylcholine receptors |
| 07/15/2003 | CA2086221C Contignasterol, and related 3-alpha hydroxy-6-alpha hydroxy-7-beta hydroxy-15-keto-14-beta steroids useful as anti-inflammatory and anti-thrombosis agent |